person · Reporting owner
MACLEOD CHRISTOPHER ROSS
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BODY & MIND INC.BAMM · Entity 94317 | Director | August 10, 2018 | January 18, 2019 |
| Zomedica Corp.ZOMDF · Entity 6884 | Director | November 17, 2025 | November 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BODY & MIND INC.
Report date August 10, 2018 · Filed January 18, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,333 |
Reported balance
Holding disclosure · report date 2018-08-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 33,333 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.66 · Expires 2022-11-24 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2018-08-10 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: Prices shown reflect Canadian dollars. |
Filing footnotes · ownership attribution and instrument terms
F1: Prices shown reflect Canadian dollars.
Zomedica Corp.
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2035-11-16 | Direct | 1,823,107 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 1,823,107 · Balance 1,823,107 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2025 Filed Nov 18, 2025 21:45 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantStock Appreciation Right · Derivative | 1,823,107 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001654954-25-013226 · section16.xml · derivative · entry 1 MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,823,107 Underlying: Common · 1,823,107 shares Expires 2035-11-16 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:48 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 143,000 | $0.06 | $8,437.00 |
DisclosureSEC source: 0001654954-25-002966 · section16.xml · nonDerivative · entry 1 MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,000 Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:11 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Appreciation Rights · Derivative | 1,823,107 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001654954-24-014268 · section16.xml · derivative · entry 1 MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,823,107 Underlying: Common · 1,823,107 shares Expires 2034-11-10 Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:04 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 1,465,727 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001654954-22-016437 · section16.xml · derivative · entry 1 MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,465,727 Underlying: Common Stock · 1,465,727 shares Expires 2032-12-09 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on December 9, 2023. Read SEC document |
| May 12, 2021 Filed May 13, 2021 14:51 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001171843-21-003478 · ownership.xml · derivative · entry 1 MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Shares, without par value · 800,000 shares Expires 2031-05-12 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing December 31, 2021. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 21:45 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 6,400 | $1.10 | $7,047.04 |
DisclosureSEC source: 0001171843-21-000778 · ownership.xml · nonDerivative · entry 1 MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 22:16 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001171843-20-004902 · ownership.xml · derivative · entry 1 MACLEOD CHRISTOPHER ROSS · CIK 0001765476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock, without par value · 175,000 shares Expires 2025-07-09 F1 · derivative.exercise_date: The options vest as to 25% on July 9, 2020, with 25% to vest annually thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.